Stock Track | Aveanna Healthcare Plunges 5.17% in Pre-Market Despite Q4 Beat as 2026 Guidance Disappoints

Stock Track

Mar 19

Aveanna Healthcare Holdings Inc. (AVAH) experienced a significant pre-market decline of 5.17% on Thursday, as investors reacted to the company's latest financial results and outlook.

The home care provider reported strong fourth-quarter 2025 results, with revenue of $662.5 million beating the IBES estimate of $645.5 million, representing a 27.4% increase year-over-year. Adjusted EBITDA climbed 54% to $85 million, driven by strength across all operating segments, particularly in the PDS division.

However, the stock's decline appears driven by the company's maintained full-year 2026 revenue guidance of $2.54 billion to $2.56 billion, which is at the low end of the FactSet consensus estimate of $2.56 billion. Despite the strong quarterly performance, this guidance suggests a more conservative growth outlook that disappointed market expectations, leading to the pre-market sell-off.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1195873076"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195873076\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195873076?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195873076","market":"nz","top_or_hot":-1,"title":"Stock Track | Aveanna Healthcare Plunges 5.17% in Pre-Market Despite Q4 Beat as 2026 Guidance Disappoints","media":"Stock Track","content":"<p>Aveanna Healthcare Holdings Inc. (AVAH) experienced a significant pre-market decline of 5.17% on Thursday, as investors reacted to the company's latest financial results and outlook.</p><p>The home care provider reported strong fourth-quarter 2025 results, with revenue of $662.5 million beating the IBES estimate of $645.5 million, representing a 27.4% increase year-over-year. Adjusted EBITDA climbed 54% to $85 million, driven by strength across all operating segments, particularly in the PDS division.</p><p>However, the stock's decline appears driven by the company's maintained full-year 2026 revenue guidance of $2.54 billion to $2.56 billion, which is at the low end of the FactSet consensus estimate of $2.56 billion. Despite the strong quarterly performance, this guidance suggests a more conservative growth outlook that disappointed market expectations, leading to the pre-market sell-off.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Aveanna Healthcare Plunges 5.17% in Pre-Market Despite Q4 Beat as 2026 Guidance Disappoints</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Aveanna Healthcare Plunges 5.17% in Pre-Market Despite Q4 Beat as 2026 Guidance Disappoints\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-19 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aveanna Healthcare Holdings Inc. (AVAH) experienced a significant pre-market decline of 5.17% on Thursday, as investors reacted to the company's latest financial results and outlook.</p><p>The home care provider reported strong fourth-quarter 2025 results, with revenue of $662.5 million beating the IBES estimate of $645.5 million, representing a 27.4% increase year-over-year. Adjusted EBITDA climbed 54% to $85 million, driven by strength across all operating segments, particularly in the PDS division.</p><p>However, the stock's decline appears driven by the company's maintained full-year 2026 revenue guidance of $2.54 billion to $2.56 billion, which is at the low end of the FactSet consensus estimate of $2.56 billion. Despite the strong quarterly performance, this guidance suggests a more conservative growth outlook that disappointed market expectations, leading to the pre-market sell-off.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVAH","symbol_name":"Aveanna Healthcare Holdings Inc.","start_time":0,"source_url":"","article_id":"1195873076","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195873076","pubTimestamp":1773921761,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Aveanna Healthcare Holdings Inc. (AVAH) experienced a significant pre-market decline of 5.17% on Thursday, as investors reacted to the company's latest financial results and outlook.The home care...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AVAH":"Aveanna Healthcare Holdings Inc."},"translate_title":"股票追踪|尽管第四季度业绩好于2026年指引令人失望，Aveanna Healthcare盘前暴跌5.17%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVAH":1},"content_text":"Aveanna Healthcare Holdings Inc. (AVAH) experienced a significant pre-market decline of 5.17% on Thursday, as investors reacted to the company's latest financial results and outlook.The home care provider reported strong fourth-quarter 2025 results, with revenue of $662.5 million beating the IBES estimate of $645.5 million, representing a 27.4% increase year-over-year. Adjusted EBITDA climbed 54% to $85 million, driven by strength across all operating segments, particularly in the PDS division.However, the stock's decline appears driven by the company's maintained full-year 2026 revenue guidance of $2.54 billion to $2.56 billion, which is at the low end of the FactSet consensus estimate of $2.56 billion. Despite the strong quarterly performance, this guidance suggests a more conservative growth outlook that disappointed market expectations, leading to the pre-market sell-off.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}